Levofloxacine Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacine Fresenius Kabi, is a fluoroquinolone antibiotic presented as a solution for injection for intravenous use. It treats a range of serious bacterial infections in adult patients.

GNH USA supplies Levofloxacine Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in various organ systems.

Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. Acute bacterial sinusitis: clears sinus infection and relieves congestion. Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and eases bronchial inflammation. Complicated urinary tract infections: eliminates resistant uropathogens and resolves infection. Complicated skin and soft‑tissue infections: targets Gram‑negative and Gram‑positive organisms for rapid healing. Intra‑abdominal infections: provides coverage against mixed aerobic and anaerobic bacteria.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: especially in older adults or those on corticosteroids. - QT interval prolongation: may precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis requiring medical attention.

Levofloxacin requires careful assessment before use. - Renal function: adjust dosing in patients with impaired renal clearance. - QT interval: avoid in patients with known prolongation or concomitant QT‑prolonging drugs. - History of tendon disorders: use with caution, particularly in older adults. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Drug interactions: review concomitant medications for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several medicines, requiring monitoring or avoidance.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption. - Warfarin: may increase INR and bleeding risk. - Cyclosporine: elevated cyclosporine levels can occur. - Other QT‑prolonging agents: additive risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - NSAIDs: increased risk of central nervous system stimulation. - Corticosteroids: heightened tendon rupture risk. - Oral hypoglycemics: potential for enhanced hypoglycaemia.